Need for Access to Enabling Technologies Drives Growth in the Contract Biomanufacturing Market
Add bookmark
Need for Access to Enabling Technologies Drives Growth in the Contract Biomanufacturing Market
Add bookmark
Eric S. Langer, Managing Partner, BioPlan Associates, joins Andrea Charles from Pharma IQ, to address how the contract manufacturing sector is adapting to the changing needs of pharma and biotech, the need for access to enabling technologies and how contract manufacturing organisations (CMOs) are increasing their client services capabilities- focusing on not only how to meet technical and scientific challenges but also how to deliver value more effectively to the client.
[inlinead]
Tags:
Eric Langer
BioPlan Associates
CMO
contract manufacturing
CMOs
contract biomanufacturing
contract manufacturing organisations
contract manufacturing organization
biomanufacturing
